Peethaambaran Kunnathoor, Chennai Saturday, May 17, 2025, 08:00 Hrs [IST] ...

Top Companies Covered In This Ketorolac Market Report: Allergan plc, Deepcare Health Pvt Ltd, Cadila Healthcare Limited, Intas Pharmaceuticals Limited, Ranbaxy Laboratories Limited, Omeros ...

Credit: Max Acronym/Shutterstock. Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an asset purchase agreement signed by the ...

RALEIGH, N.C., April 14, 2025 /PRNewswire/ -- Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of ...

Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, ...

Exhivision Media Private Limited to organsie Indore Pharma & Lab Expo, the 12th in its sequel Pharmalabchem Expo (India’s only pharmaceutical and laboratory exhibition at emerging markets), which is ...

A Triangle pharmaceutical firm is expanding its portfolio as its parent company completes a $500 million deal. © 2025 American City Business Journals. All rights ...

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, plans to assume full ...

Indore (Madhya Pradesh): Two B-Pharma students were electrocuted to death by a high tension wire in Indore’s Silicon city on Wednesday night. Both the youths are residents of Dewas. According to ...

Intas — On October 10, 2022, Intas Pharmaceuticals Ltd. purchased electoral bonds worth ₹20 crore. In December 2022, the U.S. FDA flagged serious quality control issues amounting to what it ...

The US health regulator also pointed out the company's failure to ensure that laboratory records included complete data derived from all tests necessary to ensure compliance with established ...

Intas Pharmaceuticals’ new warning letter from the U.S. FDA reads like a checklist of what not to do when the regulator pays a visit to your manufacturing facility. The FDA handed Intas a five ...